- Our Doctors
- Dr Cristian Udovicich

Dr Cristian Udovicich
MBBS, BMedSci, FRANZCR, Radiation Oncologist
Languages spoken
English
Overview
Centres
Clinical interests
Genitourinary Cancer (prostate, bladder), Central Nervous System Cancers (brain, spine, base of skull), Lung Cancer, Oligometastases, Stereotactic radiation therapy (SBRT/SABR), Stereotactic radiosurgery (SRS).
Dr Cristian Udovicich is a specialised Radiation Oncologist who has undertaken further advanced training in Australia and internationally. He uses the latest research to develop personalised treatment plans to achieve the best outcomes for patients. Dr Udovicich is passionate about patient-centred care and enabling patients to make informed decisions about their treatment. His comprehensive training has encompassed the treatment of all tumours.
Dr Udovicich completed his medical degree and postgraduate study at The University of Melbourne. He completed Radiation Oncology training at the Peter MacCallum Cancer Centre, where he was the Chief Radiation Oncology Registrar.
After training, Dr Udovicich completed two years of specialised fellowships across multiple tumour streams, including stereotactic body radiotherapy (SBRT/SABR) and stereotactic radiosurgery (SRS). He completed a clinical research fellowship at Sunnybrook Odette Cancer Centre, University of Toronto, Canada, which is one of the world's leading Radiation Oncology institutions. He was the Chief Radiation Oncology Fellow during his time in Toronto. Dr Udovicich specialised in genitourinary (prostate, bladder) and central nervous system malignancies (brain, spine). He was the inaugural Neuro-Oncology and Gamma Knife Clinical Research Fellow at Peter MacCallum Cancer Centre.
Dr Udovicich has been the recipient of multiple awards, including the University of Toronto Postgraduate Research Award, RANZCR Thomas Baker Fellowship, MIGA Grant, TOGA Travel Grant (Thoracic Oncology Group Australasia) and George Hodgson Memorial Lorne Cancer Conference Award.
Dr Udovicich has authored over 40 peer-reviewed research manuscripts published in The Lancet, European Urology and The Breast Journal and others. He has presented at international and national conferences, including as an invited speaker. He holds an honorary appointment as a Clinical Lecturer at The University of Melbourne and previously at The University of Tasmania.
Outside of work, Dr Udovicich keeps busy with his young family and is an avid Essendon Bombers supporter.
Research interests
- Prostate cancer
- Treatment of oligometastases with SBRT/SABR (stereotactic ablative body radiotherapy)
- Treatment of brain metastases with SRS (stereotactic radiosurgery)
Neuro-oncology
Professional memberships
- American Society for Radiation Oncology (ASTRO)
- European Society for Radiotherapy and Oncology (ESTRO)
- International Stereotactic Radiosurgery Society (ISRS)
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- Trans-Tasman Radiation Oncology Group (TROG)

Publications
Udovicich, C., & Loblaw, A. (2024). Prostate radiotherapy in the era of intensified systemic treatment of metastatic prostate cancer. The Lancet, 404 (10467), 2023-2026.
Udovicich, C., Cheung, P., Chu, W., Chung, H., Detsky, J., Liu, S., ... & Loblaw, A. (2025). Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials. European Urology Oncology.
Udovicich, C., Koo, K., Bryant, J. M., Bugarini, A., Huo, M., Kim, K. H., ... & Yu, H. H. M. (2025). International collaboration of neoadjuvant stereotactic radiosurgery for brain metastases: The INTERNEO individual patient data pooled analysis. Radiotherapy and Oncology, 202, 110641.
Udovicich, C., Lo, S. S., Guckenberger, M., & Sahgal, A. (2024). Shifting the Landscape of Spine and Non-Spine Bone Metastases: A Review of Stereotactic Body Radiotherapy. The Cancer Journal, 30(6), 385-392.
Udovicich, C., Jia, A. Y., Loblaw, A., Eapen, R., Hofman, M. S., & Siva, S. Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making. International Journal of Radiation Oncology, Biology, Physics.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.